In addition, we identified a trend for co-occurrence of genetic alterations in ESR1, ESR2, and PGR. Based on these results, combining the expressions of ESR1, ESR2, and PGR may provide a better prognostic value in cancer patients. This evidence concerns the gene ESR2 and cancer.